Age

18–100

Sex

MALE

Healthy volunteers

Not accepted

Clinical suspicion of prostate cancer
Able to provide informed written consent
No contraindication to prostate biopsy
Newly diagnosed treatment-naive patient with histologically proven localised adenocarcinoma of the prostate
Low or intermediate D'Amico risk prostate cancer
Sufficient quantity and quality of tissue remains from biopsy to perform genomic testing
No contraindication to radical treatment if diagnosed with localised prostate cancer
Estimated life expectancy \>10 years

Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL Evaluation